Latest Pharmaceutical manufacturing News

In Biden's big bill: Climate, health care, deficit reduction

Aug. 12, 2022 08:30 AM EDT

WASHINGTON (AP) — The biggest investment ever in the U.S. to fight climate change. A hard-fought cap on out-of-pocket prescription drug costs for Medicare recipients. A new corporate minimum tax to ensure big businesses pay their share. And billions left over to pay down federal...

J&J COVID vaccine factory forced to trash even more doses

Aug. 11, 2022 15:17 PM EDT

WASHINGTON (AP) — About 135 million more doses of Johnson & Johnson’s COVID-19 vaccine from a troubled Baltimore factory will have to be destroyed due to quality problems, Congressional panel leaders said Thursday. The announcement follows a report in May that detailed how...

What Medicare Part A’s belly-up date means for you

Aug. 10, 2022 08:31 AM EDT

At its current pace, Medicare’s Hospital Insurance trust fund will run out of money in 2028, according to the June 2022 Medicare trustees report. That’s a two-year extension on the previous estimate, but experts say it’s still not good news, and the government needs to stop twiddling its...

Major test of first possible Lyme vaccine in 20 years begins

Aug. 08, 2022 16:52 PM EDT

DUNCANSVILLE, Pa. (AP) — Researchers are seeking thousands of volunteers in the U.S. and Europe to test the first potential vaccine against Lyme disease in 20 years -- in hopes of better fighting the tick-borne threat. Lyme is a growing problem, with cases rising and warming...

Viatris, First Solar rise; Tyson Foods, Nvidia fall

Aug. 08, 2022 16:23 PM EDT

NEW YORK (AP) — Stocks that traded heavily or had substantial price changes Monday: Viatris Inc., up 36 cents to $10.09. The generic drugmaker beat Wall Street's second-quarter earnings and revenue forecasts. Tyson Foods Inc., down $7.35 to $80.10. ...

Pfizer buying spree continues with $5.4B hematology deal

Aug. 08, 2022 10:24 AM EDT

Pfizer will spend about $5.4 billion to buy Global Blood Therapeutics as the pharmaceutical giant continues to invest some of the cash influx reaped during the COVID-19 pandemic. Pfizer said Monday that the acquisition will boost its work in rare hematology. Global Therapeutics,...

BioNTech reports strong first half, expects demand to grow

Aug. 08, 2022 09:08 AM EDT

BERLIN (AP) — BioNTech, which teamed with Pfizer to develop a powerful COVID-19 vaccine, has reported higher revenue and net profit in the first half of the year and expects demand to grow as it releases updated vaccines to target new omicron strains. The German pharmaceutical...

Senate Democrats pass budget package, a victory for Biden

Aug. 07, 2022 18:48 PM EDT

WASHINGTON (AP) — Democrats pushed their election-year economic package to Senate passage Sunday, a hard-fought compromise less ambitious than President Joe Biden’s original domestic vision but one that still meets deep-rooted party goals of slowing global warming, moderating pharmaceutical...

What's in Democrats' big bill? Climate, health care, savings

Aug. 07, 2022 18:45 PM EDT

WASHINGTON (AP) — Not as robust as the proposal President Joe Biden once envisioned to rebuild America's public infrastructure and family support systems, the Democrats' compromise of health care, climate change and deficit-reduction strategies is still a substantial undertaking. ...

Dems' climate, energy, tax bill clears initial Senate hurdle

Aug. 07, 2022 01:27 AM EDT

WASHINGTON (AP) — Democrats pushed their election-year economic bill toward Senate approval early Sunday, starting the sprawling collection of President Joe Biden’s priorities on climate, energy, health and taxes on a pathway that the party hopes will end in final congressional passage by the...